Search the Appendices of Resolution CM/Res(2018)1
2309 found
INN | ATC Code ▼ | Country | Classification | Last update | MA Number | Registration date | Status | |
---|---|---|---|---|---|---|---|---|
AMINOLEVULINIC ACID | L01XD04 | IT | POM | 18-08-2017 | EMEA/H/C/000744 | 07-09-2007 | VALID | |
METHYL AMINOLEVULINATE | L01XD03 | IT | I | None | VALID | |||
CETUXIMAB | L01XC06 | IT | I | None | VALID | |||
TRASTUZUMAB | L01XC03 | IT | I | 13-05-2024 | EMEA/H/C/005769 | 15-11-2023 | VALID | |
PROCARBAZINE | L01XB01 | IT | I | None | VALID | |||
OXALIPLATIN | L01XA03 | IT | I | None | VALID | |||
NIVOLUMAB AND RELATLIMAB | L01FY02 | IT | I | 18-11-2022 | EMEA/H/C/005481 | 15-09-2022 | VALID | |
PERTUZUMAB AND TRASTUZUMAB | L01FY01 | IT | I | VALID | ||||
ELRANATAMAB | L01FX32 | IT | I | 13-05-2024 | EMEA/H/C/005908 | 07-12-2023 | VALID | |
TALQUETAMAB | L01FX29 | IT | I | 14-11-2023 | EMEA/H/C/005864 | 21-08-2023 | VALID | |
GLOFITAMAB | L01FX28 | IT | I | 14-11-2023 | EMEA/H/C/005751 | 07-07-2023 | VALID | |
LONCASTUXIMAB TESIRINE | L01FX22 | IT | I | 18-08-2023 | EMEA/H/C/005685 | 20-12-2022 | VALID | |
TREMELIMUMAB | L01FX20 | IT | I | 18-08-2023 | EMEA/H/C/004650 | 20-02-2023 | VALID | |
AMIVANTAMAB | L01FX18 | IT | I | 28-04-2022 | EMEA/H/C/005454 | 09-12-2021 | VALID | |
SACITUZUMAB GOVITECAN | L01FX17 | IT | I | 28-04-2022 | EMEA/H/C/005182 | 22-11-2021 | VALID | |
POLATUZUMAB VEDOTIN | L01FX14 | IT | I | 27-01-2022 | VALID | |||
ENFORTUMAB VEDOTIN | L01FX13 | IT | I | 18-11-2022 | EMEA/H/C/005392 | 13-04-2022 | VALID | |
TAFASITAMAB | L01FX12 | IT | I | 19-10-2021 | EMEA/H/C/005436 | 26-08-2021 | VALID | |
OLARATUMAB | L01FX10 | IT | Not authorised | 27-01-2022 | VALID | |||
MOGAMULIZUMAB | L01FX09 | IT | I | 15-07-2020 | VALID | |||
ELOTUZUMAB | L01FX08 | IT | I | 27-01-2022 | EMEA/H/C/003967 | 11-05-2016 | VALID | |
BLINATUMOMAB | L01FX07 | IT | I | 19-02-2019 | EMEA/H/C/003731 | 23-11-2015 | VALID | |
DINUTUXIMAB BETA | L01FX06 | IT | I | 27-01-2022 | VALID | |||
BRENTUXIMAB VEDOTIN | L01FX05 | IT | I | VALID | ||||
IPILIMUMAB | L01FX04 | IT | I | VALID | ||||
GEMTUZUMAB OZOGAMICIN | L01FX02 | IT | I | 17-12-2018 | EMEA/H/C/004204 | 21-09-2018 | VALID | |
RAMUCIRUMAB | L01FG02 | IT | I | VALID | ||||
TISLELIZUMAB | L01FF09 | IT | I | 14-11-2023 | EMEA/H/C/005919 | 15-09-2023 | VALID | |
DOSTARLIMAB | L01FF07 | IT | I | 19-10-2021 | EMEA/H/C/005204 | 21-04-2021 | VALID | |
CEMIPLIMAB | L01FF06 | IT | I | EMEA/H/C/004844 | 27-06-2019 | VALID | ||
ATEZOLIZUMAB | L01FF05 | IT | I | VALID | ||||
AVELUMAB | L01FF04 | IT | I | VALID | ||||
DURVALUMAB | L01FF03 | IT | I | 26-02-2020 | VALID | |||
PEMBROLIZUMAB | L01FF02 | IT | I | 27-01-2022 | EMEA/H/C/003820 | 17-07-2015 | VALID | |
NIVOLUMAB | L01FF01 | IT | I | 26-02-2020 | EMEA/H/C/003985 | 19-06-2015 | VALID | |
NECITUMUMAB | L01FE03 | IT | Not authorised | 27-01-2022 | VALID | |||
PANITUMUMAB | L01FE02 | IT | I | None | VALID | |||
TRASTUZUMAB DERUXTECAN | L01FD04 | IT | I | 19-10-2021 | EMEA/H/C/005124 | 18-01-2021 | VALID | |
TRASTUZUMAB EMTANSINE | L01FD03 | IT | I | VALID | ||||
PERTUZUMAB | L01FD02 | IT | I | None | VALID | |||
TRASTUZUMAB | L01FD01 | IT | I | VALID | ||||
ISATUXIMAB | L01FC02 | IT | I | VALID | ||||
DARATUMUMAB | L01FC01 | IT | I | 27-01-2022 | EMEA/H/C/004077 | 20-05-2016 | VALID | |
MOXETUMOMAB PASUDOTOX | L01FB02 | IT | I | 01-06-2021 | EMEA/H/C/005322 | 08-02-2021 | VALID | |
INOTUZUMAB OZOGAMICIN | L01FB01 | IT | I | VALID | ||||
OBINUTUZUMAB | L01FA03 | IT | I | VALID | ||||
OFATUMUMAB | L01FA02 | IT | I | VALID | ||||
RITUXIMAB | L01FA01 | IT | I | VALID | ||||
PRALSETINIB | L01EX23 | IT | I | 28-04-2022 | EMEA/H/C/005413 | 18-11-2021 | VALID | |
SELPERCATINIB | L01EX22 | IT | Not authorised | 01-06-2021 | VALID |